Progenics Announces JAMA Oncology Publication Highlighting Company’s Imaging Analysis Platform Read more about Progenics Announces JAMA Oncology Publication Highlighting Company’s Imaging Analysis Platform
Summary Judgment Granted Upholding the Validity of Formulation Patent Protecting RELISTOR® Injection Read more about Summary Judgment Granted Upholding the Validity of Formulation Patent Protecting RELISTOR® Injection
Progenics Pharmaceuticals Announces Three-Month Extension of PDUFA Date for AZEDRA® (iobenguane I 131) Read more about Progenics Pharmaceuticals Announces Three-Month Extension of PDUFA Date for AZEDRA® (iobenguane I 131)
Progenics Pharmaceuticals Announces Presentation of AZEDRA® (iobenguane I 131) Biochemical Tumor Marker Data at the 2018 Endocrine Society (ENDO) Annual Meeting Read more about Progenics Pharmaceuticals Announces Presentation of AZEDRA® (iobenguane I 131) Biochemical Tumor Marker Data at the 2018 Endocrine Society (ENDO) Annual Meeting
Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyL™ in Prostate Cancer Achieved Primary Endpoint Read more about Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyL™ in Prostate Cancer Achieved Primary Endpoint
Progenics to Present Results from the Phase 3 CONDOR Trial of PyL™ (18F-DCFPyL) in Prostate Cancer at the American Society of Clinical Oncology 2020 Virtual Scientific Program Read more about Progenics to Present Results from the Phase 3 CONDOR Trial of PyL™ (18F-DCFPyL) in Prostate Cancer at the American Society of Clinical Oncology 2020 Virtual Scientific Program
Lantheus Holdings to Showcase the Potential of PyL™ Imaging Agent at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting Read more about Lantheus Holdings to Showcase the Potential of PyL™ Imaging Agent at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting
Lantheus Stockholders Approve Share Issuance For Merger with Progenics Read more about Lantheus Stockholders Approve Share Issuance For Merger with Progenics
Lantheus Holdings to Present at the BMO 2020 Prescriptions for Success Virtual Healthcare Conference Read more about Lantheus Holdings to Present at the BMO 2020 Prescriptions for Success Virtual Healthcare Conference
